cobas® i 601 analyser
Enter a new dimension in mass spectrometry
With the cobas® Mass Spec solution, which includes the cobas® i 601 analyser and the Ionify® reagents line, you can step away from tedious and complex manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.
From sample preparation to result interpretation, Roche will be consolidating four technologies onto a single platform—ISE, clinical chemistry, immunochemistry, and mass spectrometry—maximising efficiency and delivering enhanced medical value. Our solution is designed to enable smart testing through seamless physical and digital connectivity with other analytical units.
A broad assay menu of Ionify reagents is in development, complementing the clinical chemistry and immunoassay portfolio available on cobas pro integrated solutions. The assays include ready-for-use test kits with consistent performance and traceability to reference methods.
Enhance your lab’s capabilities by complementing existing methodologies and expanding services to new patient populations and disease areas with mass spectrometry.1-3 The cobas i 601 analyser allows you to streamline current workflows that require dedicated and specialised staff.
Contact us to discover how mass spectrometry can seamlessly integrate into your routine laboratory, enabling broader access to this transformative technology.
Integrating mass spectrometry into routine testing
If you could envision the clinical laboratory of the future, what would it look like? The cobas® Mass Spec solution brings us closer to realising that vision, enhancing support for doctors and, ultimately, benefitting patient care. Join us on this journey and discover new possibilities for your lab.
White paper: Fuelling a new era of innovation in mass spectrometry
Looking at the challenges of broad access mass spectrometry diagnostics today, and outlining a vision for the future.
Innovation is at the core of who we are and what we do
Roche has developed new technology with our long-term partner, Hitachi High-Tech, which automates, integrates, and standardises mass spectrometry.
‘Super beads' invention automates powerful diagnostic technique
Roche’s chemistry innovation makes possible the ability to bring mass spectrometry to the routine laboratory, opening up its benefits to more clinicians and patients around the world.
5 things you should know about mass spectrometry
Learn how mass spectrometry provides a unique 'biological fingerprint' that allows for highly specific, sensitive and accurate analysis, making it a gold standard for certain clinical situations.
*Manual sample pre-treatment is still required for certain assays (e.g. immunosuppressant medicines and free medicines).
**At launch, cobas i 601 analyser is available in a single configuration <cobas pro SSU | i 601>. All other configurations, including clinical chemistry and immunochemistry analytical units, will be available at a later date.
References:
- Grebe SK, Singh RJ. LC-MS/MS in the Clinical Laboratory - Where to From Here? Clin Biochem Rev. 2011;32(1):5-31.
- Hristova J & Svinarov D. Enhancing precision medicine through clinical mass spectrometry platform. Biotechnology & Biotechnological Equipment. 2022;36(1):107-117.
- Ketha SS, Singh RJ, Ketha H. Role of Mass Spectrometry in Clinical Endocrinology. Endocrinol Metab Clin North Am. 2017;46(3):593-613.